Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/11/2019
SIETES contiene 92833 citas

 
 
 1 a 20 de 197 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Tangamornsuksan W, Lohitnavy M. Association between HLA-B*1301 and dapsone-induced cutaneous adverse drug reactions: a systematic review and meta-analysis. JAMA Dermatol 2018;154:1 de abril. [Ref.ID 102558]
2. Cita con resumen
Nordström P, Pedersen NL, Gustafson Y, Michäelsson k, Nordström A. Risks of myocardial infarction, death, and diabetes in identical twin pairs with different body mass indexes. JAMA Intern Med 2016:1 de agosto. [Ref.ID 100560]
3. Cita con resumen
Wang Y, Zhao X, Lin J, Johnston C, Lin Y, Pan Y, Liu L, Wang D, Wang C, Meng X, Xu J, for the CHANCE Investigators. Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 2016;316:70-8. [Ref.ID 100516]
4.Tiene citas relacionadas Cita con resumen
Ko TM, Tsai CY, Chen S-Y, Chen KS, Yu K-H, Chu C-S, Huang CM, Wang CR, Weng C-T, Yu C-L, Hsieh S-C, Tsai J-C, Lai W-T, Tsai W-C, Yin G-D, Ou T-T, Cheng K-H, Yen J-H, Liou T-L, Lin T-H, Chen D-Y, Hsiao P-J, Chen DY, Weng M-Y, Chen Y-M, Chen C-H, Liu F-M, Yen H-W, Lee J-J, Hung S-Y, Luo S-F, Yang Y-H, Chuang H-P, Chou Y-C, Liao H-T, Wang C-W, Huang C-L, Chen P, Wong C-S, Wu J-Y, Chen Y-T, Shen C-Y, for the Taiwan Allopurinol-SCAR Consortium. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. BMJ 2015;351:h4848. [Ref.ID 99587]
5.Tiene citas relacionadas Cita con resumen
Li-Wan-Po A. Pharmacogenetics begins to deliver on its promises. BMJ 2015;351:h5042. [Ref.ID 99584]
6.Tiene citas relacionadas Cita con resumen
Malhi GS. Lithium therapy in bipolar disorder: a balancing act?. Lancet 2015;386:415-6. [Ref.ID 99396]
7. Cita con resumen
Anónimo. Supreme Court rules human genes cannot be patented. DIA Daily 2013:14 de junio. [Ref.ID 95627]
8. Cita con resumen
Bergendal A, Adami J, Bahmanyar S, Hedenmalm K, Lärfars G, Persson I, Sundström A, Kieler H. Non-steroidal anti-inflammatory drugs and venous thromboembolism in women. Pharmacoepidemiol Drug Saf 2013;22:658-66. [Ref.ID 95564]
9. Cita con resumen
Anónimo. Genes after LABA response. Prescribing Advice for GPs 2013:8 de enero. [Ref.ID 94621]
10.Tiene citas relacionadas
Andersson C, Gislason GH, Torp-Pedersen C. Treatment with clopidogrel after myocardial infarction - Reply. JAMA 2012;308:2457. [Ref.ID 94264]
11.Tiene citas relacionadas
Lin G-M, Li Y-H, Han C-L. Treatment with clopidogrel after myocardial infarction. JAMA 2012;308:2456-7. [Ref.ID 94263]
12.Tiene citas relacionadas
Den Ruijter HM, Bots ML. Treatment with clopidogrel after myocardial infarction. JAMA 2012;308:2456. [Ref.ID 94262]
13.Tiene citas relacionadas
14.Tiene citas relacionadas Cita con resumen
Andersson C, Lyngbaek S, Nguyen CD, Gislason GH, Kober L, Torp-Pedersen C. Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and whithout diabetes. JAMA 2012;308:882-9. [Ref.ID 93727]
16.Tiene citas relacionadas Cita con resumen
De Berardis G, Lucisano G, D'Ettorre A, Pllegrini F, Lepore V, Tognoni G, Nicolucci A. Association of aspirin use with major bleeding in patients with and without diabetes. JAMA 2012;307:2286-94. [Ref.ID 93177]
17. Cita con resumen
Clarke R, Bennett DA, Parish S, Verhoef P, Dötsch-Klerk M, Lathrop M, Xu P, Nordestgaard BG, Holm H, Hopewell JC, Saleheen D, Tanaka T, Anand SS, Chambers JC, Kleber ME, Ouwehand WH, Yamada Y, Elbers C, Peters B, Stweart AFR, Reilly MM, Thorand B, Yusuf S, Engert JC, Assimes TL, Kooner J, Danesh J, Watkins H, Samani NJ, Collins R, Peto R, for the MTHFR Studies Collaborative Group. Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLOS Medicine 2012:febrero. [Ref.ID 92301]
18. Cita con resumen
Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E, Wang H, Martin M, Cotrina J, Gomez H, Hubbard R, Chacón JI, Ferrer-Lozano J, Dyer R, Buxton M, Gong Y, Wu Y, Ibrahim N, Andreopoulou E, Ueno NT, Hunt K, Yang W, Nazario A, DeMichele A, O0Shaughnessy J, Hortobagyi GN, Symmans WF. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 2011;305:1873-81. [Ref.ID 90795]
19. Cita con resumen
Domchek SM, Friebel TM, Singer CF, Evans DGL, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van t'veer L, Tung N, Weitzel JN, Couch FJ, Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Schildkraut J, Blum JL, Rebbeck TR. Association or risc-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010;304:967-75. [Ref.ID 89281]
Seleccionar todas
 
 1 a 20 de 197 siguiente >>